Search - tctmd.com

Displaying 81 - 92 of 92

Sort: Relevancy | Date

Video

» Topical Discussion

Optimizing the TAVR Patient Pathway

March 21, 2019

Video

» Interview

ACC 2019: Outcomes of Transcatheter Aortic Valve Replacement with Balloon-Expandable Sapien3 Valve in Bicuspid Aortic Stenosis: An Analysis of the STS/TVT Registry

March 18, 2019

Video

» Interview

ACC 2019: Self-Expanding Transcatheter or Surgical Aortic Valve Replacement in Patients at Low Risk of Surgical Mortality

March 18, 2019

Video

» Interview

ACC 2019: PARTNER 3 - Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients

March 18, 2019

Video

» Talking TAVR

Talking TAVR - TAVR/LAAO

January 9, 2019

Video

» Talking TAVR

Talking TAVR: OBSERVANT

January 9, 2019

Video

SHDS 2018: Early Commercial Experience Using the PORTICO Transcatheter Aortic Valve: 30-Day Outcomes in 973 Patients Enrolled in the Portico I Study (Cohort A)

July 4, 2018

Video

SHDS 2018: Keynote Lecture #2: Useful and Evolving Biomarkers In Aortic Stenosis and TAVR - Current Status and Future Directions

July 4, 2018

Video

SHDS 2018: Point: TAVR will be the Treatment of Choice for Bicuspid Aortic Valve Disease in the Future!

June 26, 2018

Video

SHDS 2018: Counterpoint: Most Bicuspid Aortic Valves (Especially In Younger Low-Risk Patients) Will Remain in the Surgical Domain!

June 26, 2018

Video

SHDS 2018: An Introduction to “VARC-3: A Focused Update” – New Endpoints and Definitions for Aortic Valve Clinical Research

June 26, 2018

Video

SHDS 2018: Multisociety Appropriate Use Criteria for the Treatment of Patients With Severe Aortic Stenosis: A Useful Guide for Clinical Decision-Making?

June 26, 2018

Advertisement

Optimizing the TAVR Patient Pathway

ACC 2019: Outcomes of Transcatheter Aortic Valve Replacement with Balloon-Expandable Sapien3 Valve in Bicuspid Aortic Stenosis: An Analysis of the STS/TVT Registry

ACC 2019: Self-Expanding Transcatheter or Surgical Aortic Valve Replacement in Patients at Low Risk of Surgical Mortality

ACC 2019: PARTNER 3 - Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients

Talking TAVR - TAVR/LAAO

Talking TAVR: OBSERVANT

SHDS 2018: Early Commercial Experience Using the PORTICO Transcatheter Aortic Valve: 30-Day Outcomes in 973 Patients Enrolled in the Portico I Study (Cohort A)

SHDS 2018: Keynote Lecture #2: Useful and Evolving Biomarkers In Aortic Stenosis and TAVR - Current Status and Future Directions

SHDS 2018: Point: TAVR will be the Treatment of Choice for Bicuspid Aortic Valve Disease in the Future!

SHDS 2018: Counterpoint: Most Bicuspid Aortic Valves (Especially In Younger Low-Risk Patients) Will Remain in the Surgical Domain!

SHDS 2018: An Introduction to “VARC-3: A Focused Update” – New Endpoints and Definitions for Aortic Valve Clinical Research

SHDS 2018: Multisociety Appropriate Use Criteria for the Treatment of Patients With Severe Aortic Stenosis: A Useful Guide for Clinical Decision-Making?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content